Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
Rapid Communications in Mass Spectrometry January 15, 2016 Giampietro Frison, L. Zamengo, Flavio Zancanaro et al.
Rationale Clinical and forensic toxicology laboratories are challenged every day by the analytical aspects of the new psychoactive substances phenomenon. In this study we describe the analytical characterization of a new ketamine derivative, deschloroketamine (2‐methylamino‐2‐phenylcyclohexanone), contained in seized powders. Methods The analytical techniques employed include gas...